William Blair analyst Maggie Nolan has maintained their bullish stance on ASGN stock, giving a Buy rating on January 27.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Maggie Nolan has given his Buy rating due to a combination of factors that underscore ASGN’s improving fundamentals and positive strategic trajectory. The company delivered fourth-quarter revenue and margin performance that exceeded expectations even after a prior upbeat preannouncement, indicating underlying operational strength despite a modest adjusted EPS shortfall driven by tax effects. In addition, first-quarter guidance, excluding the Quinnox acquisition, points to continued resilience with slightly better-than-anticipated revenue and margins, supporting confidence in near-term execution.
Maggie Nolan’s rating is based on the view that ASGN’s consulting business and upcoming catalysts provide solid growth visibility. Commercial consulting continues to show steady expansion, with accelerating revenue growth, robust bookings, and healthy book-to-bill metrics across key verticals such as consumer, industrial, healthcare, and a recovering technology/media/telecom segment. The Quinnox acquisition is expected to enhance ASGN’s offshore delivery capabilities in India, provide incremental revenue upside through 2026, and lift long-term commercial EBITDA margins given Quinnox’s higher profitability profile. Furthermore, the federal segment is positioned to recover as the impact from DOGE-related disruptions subsides by the end of the first quarter and management anticipates strong award activity in the first half of 2026, reinforcing the longer-term growth outlook.
Nolan covers the Technology sector, focusing on stocks such as Cognizant, ASGN, and Genpact. According to TipRanks, Nolan has an average return of 0.3% and a 53.54% success rate on recommended stocks.
In another report released on January 27, Truist Financial also maintained a Buy rating on the stock with a $60.00 price target.